ADRX

ADARx Pharmaceuticals develops prescription medicines and is listed under the drug preparations category. The company appears to be newly public, with shares first trading in late September 2026. Companies at this stage usually have no approved products and earn little or no sales, so they rely on money raised from investors to fund research. Our data feeds carry no business description for ADARx, so details on its drug pipeline are not available here.